Today: 19 April 2026
Browse Category

LSE:AV. 13 November 2025 - 27 November 2025

Aviva (LON: AV.) Share Price Today, 27 November 2025: Citigroup Target Cut, Green Loan Push and 5.7% Dividend in Focus

Aviva (LON: AV.) Share Price Today, 27 November 2025: Citigroup Target Cut, Green Loan Push and 5.7% Dividend in Focus

Aviva shares rose about 0.4% to 653p in London trading Thursday, extending a strong 2025 rally. Citigroup trimmed its price target to 671p but kept a neutral rating, while other analysts remain split. The stock hit a range of 650p–657p during the session. Aviva is trading near multi-year highs after acquiring Direct Line and launching new sustainability and tech initiatives.
27 November 2025
Aviva share price climbs as green loan, cyber push and portfolio shake‑up headline 26 November news

Aviva share price climbs as green loan, cyber push and portfolio shake‑up headline 26 November news

Aviva shares rose about 1% to 650p in London after the insurer announced a £32m green loan for a logistics site in Enfield and launched new cyber-risk training. The group is divesting from By Miles, dropping a €2.9bn high-yield strategy, and faces a key High Court transfer hearing today. Aviva’s market value stands near £19.7bn, up 35% over 12 months.
FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next

UK Stocks Today (13 Nov 2025): FTSE 100 slips as 3i plunges, Aviva underwhelms; weak Q3 GDP and softer oil weigh on London

The FTSE 100 dropped about 1% Thursday, ending its streak of record closes as financial and energy shares fell. UK GDP grew just 0.1% in Q3, missing forecasts and boosting bets on a December Bank of England rate cut. 3i Group plunged over 14%, while Burberry and Wizz Air shares rallied on strong results. Sterling edged up 0.2% against the dollar.
Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies

Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies

Aviva shares fell 4.04% to 664.60p by 09:53 GMT after its third-quarter update and new medium-term targets. The company raised synergy targets from the Direct Line deal and guided to £2.2bn operating profit for 2025, but the stock dropped after a strong year-to-date rally. General insurance premiums rose 12% to £10bn for the first nine months. Management signaled share buybacks may resume with 2025 results.
13 November 2025

Stock Market Today

  • Schaeffler India to Pay ₹35 Dividend as Earnings and Cash Flow Support Sustainability
    April 18, 2026, 10:41 PM EDT. Schaeffler India Limited (NSE:SCHAEFFLER) is set to go ex-dividend on April 23, with a dividend payment of ₹35 per share scheduled for May 30. The company's dividend yield stands at approximately 0.9% based on the current share price of ₹4,002.50. Schaeffler India's dividend payout ratio is a conservative 48% of earnings and consumes 53% of free cash flow, indicating the dividend is well covered and likely sustainable. Notably, the company has experienced robust earnings growth, with a 32% average annual increase over the past five years. Dividend growth has averaged 37% annually for the past decade. This blend of strong earnings expansion and prudent payout ratios suggests a reliable income stream for investors.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Go toTop